StockDuty ← Dashboard Aug 10, 2026 11:29 AM ET
CatalystFDA/Bio

Innate Pharma Jumps After Sobi Deal To Advance Lacutamab Into Phase 3; Appoints Markus Jensen As CMO

Innate Pharma Jumps After Sobi Deal To Advance Lacutamab Into Phase 3; Appoints Markus Jensen As CMO

Sources